Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England
Authors:
- Sophie EdwardsSESophie Edwards
- Dominic TrepelDTDominic Trepel
- Craig RitchieCRCraig Ritchie
- Julie Hviid Hahn-PedersenJHJulie Hviid Hahn-Pedersen
- Danielle E RobinsonDRDanielle E Robinson
- Mei Sum ChanMCMei Sum Chan
- Benjamin D BrayBBBenjamin D Bray
- Alice ClarkACAlice Clark
- Milana IvkovicMIMilana Ivkovic
- Wojciech MichalakWMWojciech Michalak
- Christian Ahmad WichmannCWChristian Ahmad Wichmann
- Marc EvansMEMarc Evans
Open Access
- 22 January 2024
- journal article
- research article
- Published by Elsevier in Aging and Health Research
- Vol. 4 (1)
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological TraitsFrontiers in Neuroscience, 2018
- Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death?The European Journal of Health Economics, 2017
- Frailty in Older PersonsClinics in Geriatric Medicine, 2017
- Direct and indirect cost of managing alzheimer’s disease and related dementias in the United StatesExpert Review of Pharmacoeconomics & Outcomes Research, 2017
- Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case registerBMJ Open, 2016
- The burden of disease in older people and implications for health policy and practiceThe Lancet, 2015
- Association between Stroke and Alzheimer's Disease: Systematic Review and Meta-AnalysisJournal of Alzheimer’s Disease, 2014
- Review of statistical methods for analysing healthcare resources and costsHealth Economics, 2010
- Depression and Risk for Alzheimer DiseaseArchives of General Psychiatry, 2006
- Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteinsThe Lancet, 2004